Absence of systemic toxicity changes following intramuscular administration of novel pSG2.HIVconsv DNA, ChAdV63.HIVconsv and MVA.HIVconsv vaccines to BALB/c mice.
about
Safety and tolerability of conserved region vaccines vectored by plasmid DNA, simian adenovirus and modified vaccinia virus ankara administered to human immunodeficiency virus type 1-uninfected adults in a randomized, single-blind phase I trial.Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1.Immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics.The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes.Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1.
P2860
Absence of systemic toxicity changes following intramuscular administration of novel pSG2.HIVconsv DNA, ChAdV63.HIVconsv and MVA.HIVconsv vaccines to BALB/c mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Absence of systemic toxicity c ...... consv vaccines to BALB/c mice.
@en
Absence of systemic toxicity c ...... consv vaccines to BALB/c mice.
@nl
type
label
Absence of systemic toxicity c ...... consv vaccines to BALB/c mice.
@en
Absence of systemic toxicity c ...... consv vaccines to BALB/c mice.
@nl
prefLabel
Absence of systemic toxicity c ...... consv vaccines to BALB/c mice.
@en
Absence of systemic toxicity c ...... consv vaccines to BALB/c mice.
@nl
P2093
P2860
P1433
P1476
Absence of systemic toxicity c ...... consv vaccines to BALB/c mice.
@en
P2093
Alfredo Nicosia
Beatrice Ondondo
Caroline Brennan
Steven J Crome
Tomáš Hanke
P2860
P304
P356
10.1016/J.VACCINE.2013.06.068
P407
P577
2013-07-02T00:00:00Z